These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8730399)
1. Evidence for a pivotal role of platelets in vascular reocclusion and restenosis. LeBreton H; Topol E; Plow EF Cardiovasc Res; 1996 Feb; 31(2):235-6. PubMed ID: 8730399 [No Abstract] [Full Text] [Related]
2. Thrombin or platelets as major point of impact in vascular reocclusion and restenosis; a controversy? Levi M Cardiovasc Res; 1996 Feb; 31(2):231. PubMed ID: 8730397 [No Abstract] [Full Text] [Related]
3. Thrombin plays a pivotal role in vascular re-occlusion after PTCA and coronary thrombolysis. Agnelli G Cardiovasc Res; 1996 Feb; 31(2):232-4. PubMed ID: 8730398 [No Abstract] [Full Text] [Related]
4. [Local treatment during angioplasty]. Brasselet C; Addad F; Lemarchand P; Lafont A Arch Mal Coeur Vaiss; 1999 Nov; 92(11 Suppl):1699-706. PubMed ID: 10598253 [TBL] [Abstract][Full Text] [Related]
5. Double-trouble: three cases with simultaneous stent thrombosis in different coronary arteries. van Werkum JW; Seesing TH; Suttorp MJ; Bal ET; den Heijer P; Ten Berg JM J Interv Cardiol; 2007 Apr; 20(2):132-5. PubMed ID: 17391221 [TBL] [Abstract][Full Text] [Related]
6. Percutaneous coronary intervention for acute myocardial infarction: current strategy in the lab. Haranath SP; Grines C Indian Heart J; 2007; 59(2 Suppl B):B86-98. PubMed ID: 19153441 [No Abstract] [Full Text] [Related]
7. Coronary thrombosis in a patient with leukemic thrombocytosis: which was the best treatment? Delcrè S; Bollati M; Moretti C; Biondi-Zoccai GG; Anselmino M; Laudito A; Sheiban I Minerva Cardioangiol; 2008 Apr; 56(2):263. PubMed ID: 18319708 [No Abstract] [Full Text] [Related]
8. Dynamics of coronary thrombolysis and reocclusion. Becker R Clin Cardiol; 1997 Nov; 20(11 Suppl 3):III2-5. PubMed ID: 9422855 [TBL] [Abstract][Full Text] [Related]
9. In-stent thrombosis after discontinuation of antiplatelet therapy 2 years after DES implantation: a case report. De Luca G; Carbone G; Maione A; Gregorio G Int J Cardiol; 2007 Apr; 116(3):399-400. PubMed ID: 17258334 [No Abstract] [Full Text] [Related]
15. High incidence of recurrent in stent thrombosis after successful treatment of a first in stent thrombosis. Lemesle G; Sudre A; Modine T; Delhaye C; Rosey G; Gourlay T; Bauters C; Lablanche JM Catheter Cardiovasc Interv; 2008 Oct; 72(4):470-8. PubMed ID: 18814219 [TBL] [Abstract][Full Text] [Related]
16. Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients. Ziegler S; Maca T; Alt E; Speiser W; Schneider B; Minar E Platelets; 2002 Dec; 13(8):493-7. PubMed ID: 12487783 [TBL] [Abstract][Full Text] [Related]
17. Role of platelets in restenosis after percutaneous coronary revascularization. Le Breton H; Plow EF; Topol EJ J Am Coll Cardiol; 1996 Dec; 28(7):1643-51. PubMed ID: 8962547 [TBL] [Abstract][Full Text] [Related]
18. Emerging insights on antiplatelet therapy. Introduction. Angiolillo DJ Am J Cardiol; 2009 Feb; 103(3 Suppl):1A-3A. PubMed ID: 19166706 [No Abstract] [Full Text] [Related]
19. [Drug-eluting stents--for all, for some or for none?--Editorial]. Kocka V; Widimský P Vnitr Lek; 2007 Oct; 53(10):1033-4. PubMed ID: 18072425 [No Abstract] [Full Text] [Related]
20. Which patients receiving warfarin can be treated safely with a drug-eluting stent? Ryding AD; Banning AP Heart; 2008 Mar; 94(3):275-7. PubMed ID: 18276815 [No Abstract] [Full Text] [Related] [Next] [New Search]